Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 205082
Company: ACTAVIS MID ATLANTIC

Products on ANDA 205082

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DESOXIMETASONE	DESOXIMETASONE	0.25%	CREAM;TOPICAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 205082

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/04/2015	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/205082Orig1s000ltr.pdf

Therapeutic Equivalents for ANDA 205082

DESOXIMETASONE

CREAM;TOPICAL; 0.25%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DESOXIMETASONE	DESOXIMETASONE	0.25%	CREAM;TOPICAL	Prescription	No	AB	205082	ACTAVIS MID ATLANTIC
DESOXIMETASONE	DESOXIMETASONE	0.25%	CREAM;TOPICAL	Prescription	No	AB	078369	FOUGERA PHARMS
DESOXIMETASONE	DESOXIMETASONE	0.25%	CREAM;TOPICAL	Prescription	No	AB	208164	LUPIN
DESOXIMETASONE	DESOXIMETASONE	0.25%	CREAM;TOPICAL	Prescription	No	AB	076510	PADAGIS ISRAEL
DESOXIMETASONE	DESOXIMETASONE	0.25%	CREAM;TOPICAL	Prescription	No	AB	205594	RISING
DESOXIMETASONE	DESOXIMETASONE	0.25%	CREAM;TOPICAL	Prescription	No	AB	205620	ZYDUS LIFESCIENCES
TOPICORT	DESOXIMETASONE	0.25%	CREAM;TOPICAL	Prescription	No	AB	073193	TARO